Squarepoint Ops LLC Gossamer Bio, Inc. Transaction History

Squarepoint Ops LLC

$99.2 Billion
Q4 2024

A detailed history of Squarepoint Ops LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 71,944 shares of GOSS stock, worth $87,052. This represents 0.0% of its overall portfolio holdings.

Number of Shares

71,944

Previous 146,957 51.04%

Holding current value

$87,052

Previous $145,000 55.86%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.66 - $1.07 $49,508 - $80,263	-75,013 Reduced 51.04%	71,944 $64,000
Q3 2024 Nov 14, 2024	BUY	$0.79 - $1.25 $116,096 - $183,696	146,957 New	146,957 $145,000
Q1 2024 May 15, 2024	BUY	$0.8 - $1.51 $202,874 - $382,925	253,593 Added 546.05%	300,034 $354,000
Q4 2023 Feb 14, 2024	SELL	$0.48 - $1.08 $49,738 - $111,911	-103,622 Reduced 69.05%	46,441 $42,000
Q2 2023 Aug 14, 2023	SELL	$0.98 - $1.53 $499,664 - $780,088	-509,862 Reduced 77.26%	150,063 $180,000
Q1 2023 May 15, 2023	SELL	$0.96 - $2.92 $244,800 - $744,602	-255,001 Reduced 27.87%	659,925 $831,000
Q4 2022 Feb 14, 2023	BUY	$1.74 - $12.87 $1.17 Million - $8.68 Million	674,380 Added 280.35%	914,926 $1.99 Million
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $1.5 Million - $3.09 Million	207,985 Added 638.75%	240,546 $2.88 Million
Q2 2022 Aug 15, 2022	SELL	$5.97 - $9.97 $108,570 - $181,314	-18,186 Reduced 35.84%	32,561 $273,000
Q1 2022 May 16, 2022	BUY	$8.44 - $12.49 $428,304 - $633,830	50,747 New	50,747 $440,000
Q3 2021 Nov 15, 2021	SELL	$7.25 - $13.23 $76,668 - $139,907	-10,575 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$8.0 - $9.75 $156,904 - $191,226	-19,613 Reduced 64.97%	10,575 $86,000
Q1 2021 May 17, 2021	SELL	$8.63 - $10.94 $206,507 - $261,783	-23,929 Reduced 44.22%	30,188 $279,000
Q4 2020 Feb 16, 2021	BUY	$8.3 - $13.59 $330,597 - $541,303	39,831 Added 278.81%	54,117 $523,000
Q3 2020 Nov 16, 2020	BUY	$11.3 - $14.75 $4,440 - $5,796	393 Added 2.83%	14,286 $177,000
Q2 2020 Aug 14, 2020	SELL	$9.52 - $15.98 $42,173 - $70,791	-4,430 Reduced 24.18%	13,893 $181,000
Q1 2020 May 15, 2020	SELL	$8.0 - $15.48 $120,912 - $233,964	-15,114 Reduced 45.2%	18,323 $186,000
Q4 2019 Feb 14, 2020	BUY	$14.82 - $26.79 $495,536 - $895,777	33,437 New	33,437 $523,000

Others Institutions Holding GOSS

# of Institutions

116

Shares Held

163M

Call Options Held

821K

Put Options Held

557K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $114M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Gossamer Bio, Inc. Transaction History